Ashley Perry

643 citations
36 papers · 362 indexed · h-index 10
Topics
Acute Myeloid Leukemia Research (9 papers)Glioma Diagnosis and Treatment (4 papers)Multiple Myeloma Research and Treatments (3 papers)
Partner nations
United States

In The Last Decade

Ashley Perry

31 papers receiving 355 citations

Peers

Ashley Perry
Comparison fields: 5 of 71
  • Hematology 130
  • Genetics 92
  • Molecular Biology 84
  • Cancer Research 68
  • Sociology and Political Science 54
Replace Chien‐Chin Lin with:
Chien‐Chin Lin Taiwan
Kathleen Shannon Dorcy United States
Xiong Ni China
Nicolas Batty United States
Aric Parnes United States
Kyriaki Michailidou Cyprus
Rose M. Kakoza United States
John P. Galvin United States
Deborah Richardson United Kingdom
Amy Anderson United States
Ashley Perry relative to Chien‐Chin Lin Taiwan Chien‐Chin Lin's profile →
Citations per field
00.5×8.7×
Chien‐Chin Lin · 1×
Citations per year

Countries citing papers authored by Ashley Perry

Since Specialization
Citations

This map shows the geographic impact of Ashley Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Perry more than expected).

Fields of papers citing papers by Ashley Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Perry. The network helps show where Ashley Perry may publish in the future.

Co-authorship network of co-authors of Ashley Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Perry. A scholar is included among the top collaborators of Ashley Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Perry. Ashley Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 0
5 6
6 2
7 4
8 1
9 1
10 1
11 25
12 10
13 57
14 59
15 2
16 19
17 8
18 11
19 8
20
Phase I-II diaziquone chemotherapy in brain tumors.
1

About Ashley Perry

Ashley Perry is a scholar working on Hematology, Genetics and General Health Professions, having authored 36 papers that have together received 362 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Glioma Diagnosis and Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (130 citations), Genetics (92 citations) and Cancer Research (68 citations). Ashley Perry has collaborated with scholars based in United States. Frequent co-authors include Miguel Muñoz‐Laboy, Eyal C. Attar, Vincent Guilamo‐Ramos, Karen K. Ballen, Philip C. Amrein, Hossein Sadrzadeh, Donna Neuberg, Andrew M. Brunner, Amir T. Fathi and Traci M. Blonquist. Their work appears in journals such as Blood, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026